EUVIMEDEUVIMED entdecken
Fallbericht

A case of glucocorticoid-refractory IgA vasculitis with diffuse alveolar haemorrhage: A therapeutic strategy for aberrant immunoglobulin depletion

Kazuhiko Hirokawa iD, Shunichi Sato, Eiji Hiraoka, Keiichi Iwanami iD

Modern Rheumatology Case Reports · 2025

DOI: 10.1093/mrcr/rxae087 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Modern Rheumatology Case Reports, 2025. Verfasst von Kazuhiko Hirokawa und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Tokyo Bay Urayasu Ichikawa Medical Center, Chiba, Japan. Hauptthemen laut MEDLINE: Hemorrhage, Immunoglobulin A, Plasma Exchange, Vasculitis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diffuse alveolar haemorrhage (DAH) is a rare and severe complication of IgA vasculitis (IgAV). Although glucocorticoids and immunosuppressive agents are used for its treatment, there is no consensus on the optimal form of treatment. We herein report the case of a 53-year-old, female patient with IgAV. She was initially resistant to glucocorticoid therapy and experienced acute respiratory failure due to DAH but responded well to rituximab (RTX) and plasma exchange (PLEX). While some previous case reports have suggested that RTX or PLEX can be effective for severe IgAV, there are no reports of a combination of RTX and PLEX being used successfully to treat IgAV-associated DAH. In the model of IgAV pathogenesis proposed herein, aberrant IgA1 and IgA-specific IgG autoantibodies play a pivotal role. PLEX may facilitate the prompt removal of these circulating, aberrant immunoglobulins while RTX inhibits their further production. Consequently, a combination of RTX and PLEX may represent an effective treatment approach for severe glucocorticoid-refractory cases of IgAV.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HemorrhageImmunoglobulin APlasma ExchangeVasculitisLung DiseasesHumansFemaleMiddle AgedGlucocorticoidsRituximabPulmonary AlveoliTreatment OutcomeImmunologic Factors

Stichwörter der Autor:innen

IgA vasculitisaberrant immunoglobulinsdiffuse alveolar haemorrhageplasma exchangerituximab

Substanzen

GlucocorticoidsRituximabImmunoglobulin AImmunologic Factors

Autor:innen und Institutionen

  • Department of Internal Medicine, Tokyo Bay Urayasu Ichikawa Medical Center, Chiba, Japan.
  • Department of Rheumatology, Tokyo Bay Urayasu Ichikawa Medical Center, Chiba, Japan.

ORCID-Profile: Kazuhiko Hirokawa, Keiichi Iwanami

Zitieren

APA

Hirokawa, K., Sato, S., Hiraoka, E., & Iwanami, K. (2025). A case of glucocorticoid-refractory IgA vasculitis with diffuse alveolar haemorrhage: A therapeutic strategy for aberrant immunoglobulin depletion. Modern Rheumatology Case Reports. https://doi.org/10.1093/mrcr/rxae087

Vancouver

Hirokawa K, Sato S, Hiraoka E, Iwanami K. A case of glucocorticoid-refractory IgA vasculitis with diffuse alveolar haemorrhage: A therapeutic strategy for aberrant immunoglobulin depletion. Modern Rheumatology Case Reports. 2025. doi:10.1093/mrcr/rxae087

BibTeX
@article{Hirokawa2025,
  author = {Hirokawa, Kazuhiko and Sato, Shunichi and Hiraoka, Eiji and Iwanami, Keiichi},
  title = {A case of glucocorticoid-refractory IgA vasculitis with diffuse alveolar haemorrhage: A therapeutic strategy for aberrant immunoglobulin depletion},
  journal = {Modern Rheumatology Case Reports},
  year = {2025},
  doi = {10.1093/mrcr/rxae087}
}
Kostenlos starten →